Vitroscope AS

We aim to increase preclinical drug testing accuracy by 10% by 2025 in order to significantly reduce drug development costs. By allowing to efficiently observe cells under mechanical stress we can replicate in vivo conditions.
With our patent pending technology we have a great starting point to tackle our ambitious goals.